Public Law 113–260: To amend the Controlled Substances Act to more effectively regulate anabolic steroids.

5α-Androstan-3,6,17-trione;

6-bromo-androstan-3,17-dione;

6-bromo-androsta-1,4-diene-3,17-dione;

4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;

4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;

4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one;

4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione;

4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;

2α,17α-dimethyl-17β-hydroxy-5α-androstan-3-one;

2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one;

2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;

[3,2-c]-furazan-5α-androstan-17β-ol;

3β-hydroxy-estra-4,9,11-trien-17-one;

17α-methyl-androst-2-ene-3,17β-diol;

17α-methyl-androsta-1,4-diene-3,17β-diol;

Estra-4,9,11-triene-3,17-dione;

18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one;

6α-Methyl-androst-4-ene-3,17-dione;

17α-Methyl-androstan-3-hydroxyimine-17β-ol;

17α-Methyl-5α-androstan-17β-ol;

17β-Hydroxy-androstano[2,3-d]isoxazole;

17β-Hydroxy-androstano[3,2-c]isoxazole;

4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5α-androstan-17β-ol;

[3,2-c]pyrazole-androst-4-en-17β-ol;

[3,2-c]pyrazole-5α-androstan-17β-ol; and”

Subject to clause (ii), a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed in subparagraph (A) and is derived from, or has a chemical structure substantially similar to, 1 or more anabolic steroids listed in subparagraph (A) shall be considered to be an anabolic steroid for purposes of this Act if—

“(I)

A substance shall not be considered to be a drug or hormonal substance for purposes of this subparagraph if it—

“(I)

In accordance with section 515(a), any person claiming the benefit of an exemption or exception under clause (ii) shall bear the burden of going forward with the evidence with respect to such exemption or exception.”

the drug or other substance satisfies the criteria for being considered an anabolic steroid under section 102(41) but is not listed in that section or by regulation of the Attorney General as being an anabolic steroid; and

adding such drug or other substance to the definition of anabolic steroids will assist in preventing abuse or misuse of the drug or other substance.

A product described in subparagraph (B) is exempt from the International Union of Pure and Applied Chemistry nomenclature requirement of this subsection if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act.

A product is described in this subparagraph if the product—

“(ii)

to violate subsection (e) of section 825 of this title.”

In the case of a violation of paragraph (16) of subsection (a) of this section by an importer, exporter, manufacturer, or distributor (other than as provided in subparagraph (D)), up to $500,000 per violation. For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute, in violation of paragraph (16) of subsection (a).

In the case of a distribution, dispensing, or possession with intent to distribute or dispense in violation of paragraph (16) of subsection (a) of this section at the retail level, up to $1000 per violation. For purposes of this paragraph, the term ‘’ refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation of such paragraph (16) of subsection (a) shall be considered a separate violation.”